Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
ResMed Stock Quote

ResMed (NYSE: RMD)

$185.09
(-0.4%)
-$0.77
Price as of April 15, 2024, 4:00 p.m. ET

ResMed Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
RMD -16.73% +98.73% +14.72% +32,536%
S&P +23.57% +76.22% +11.98% +851%

ResMed Company Info

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

News & Analysis

The Fool has written over 100 articles on ResMed.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.